Nu Skin Enterprises (NUS) EBT (2009 - 2026)

Nu Skin Enterprises (NUS) has 18 years of EBT data on file, last reported at $2.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 98.07% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $64.2 million (down 67.27% YoY), and the FY2025 full-year result was $196.2 million, up 213.2% from the prior year.
• EBT retreated to $2.6 million in Q1 2026, from $18.2 million in the prior quarter.
• In the past five years, EBT ranged from a high of $179.9 million in Q4 2024 to a low of -$131.6 million in Q2 2024.
• A 5-year average of $18.4 million and a median of $16.0 million in 2025 frame the typical range for EBT.
• Across the five-year window, EBT slumped 454.72% in 2024 and surged 12125.34% in 2025, its largest moves.
• Tracing NUS's EBT over 5 years: stood at $24.4 million in 2022, then slumped by 323.37% to -$54.4 million in 2023, then surged by 430.67% to $179.9 million in 2024, then slumped by 89.89% to $18.2 million in 2025, then slumped by 85.71% to $2.6 million in 2026.
• Business Quant data shows NUS's EBT at $2.6 million in Q1 2026, $18.2 million in Q4 2025, and $16.0 million in Q3 2025.